Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
Titel:
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
Auteur:
Spiegelberg, Linda Houben, Ruud Niemans, Raymon de Ruysscher, Dirk Yaromina, Ala Theys, Jan Guise, Christopher P. Smaill, Jeffrey B. Patterson, Adam V. Lambin, Philippe Dubois, Ludwig J.